SweetValueLab
Write for us

Ameren Corporation — Wall Street Analyst Estimates & Price Targets

AEE
NYSEUtilitiesRegulated ElectricCIK 0001002910amereninvestors.comAbout AEE
Last close · Oct 16, 2026106.08+2.32 (+2.24%)
Market cap$29.4B

7 firms' latest targets, last 90 days: median $116.00 ($104.00–$126.00), 9% above the last close.

Price and published targets

daily close, 12 months · each dot a target, a firm's latest darker
$100$110$120$130NovJan 2026MarMayJulSep2025-10-21 · Barclays: $1112025-10-21 · Barclays: $1132025-10-22 · Morgan Stanley: $1112025-10-27 · Wells Fargo: $1122025-10-27 · RBC Capital: $1192025-10-27 · Mizuho Securities: $1142025-12-16 · Morgan Stanley: $1032025-12-17 · UBS: $1152026-01-15 · Barclays: $1042026-01-20 · Wells Fargo: $1112026-01-21 · Morgan Stanley: $1082026-01-23 · RBC Capital: $1162026-02-13 · Wells Fargo: $1132026-02-13 · Mizuho Securities: $1172026-02-13 · BMO Capital: $1202026-02-20 · Morgan Stanley: $1162026-02-20 · UBS: $1272026-04-09 · BTIG: $1312026-04-15 · Barclays: $1162026-04-20 · Truist: $1262026-04-21 · Morgan Stanley: $1172026-04-21 · Wells Fargo: $1202026-05-21 · Morgan Stanley: $1102026-06-24 · Morgan Stanley: $1152026-07-09 · Barclays: $1172026-07-22 · Morgan Stanley: $1182026-07-23 · BTIG: $1262026-07-23 · KeyBanc: $1222026-08-03 · Mizuho Securities: $1242026-08-17 · Truist: $1202026-09-25 · RBC Capital: $1072026-09-29 · Scotiabank: $1042026-09-30 · Mizuho Securities: $1132026-10-13 · KeyBanc: $1162026-10-14 · Truist: $116
$100$110$120$130NovFebMayAug

Each firm's latest target

last 90 days · 7 firms
DateFirmTargetPreviousChangeVs price thenVs price now
2026-10-14Truist$116.00$120.00▼ 3%+11%+9%
2026-10-13KeyBanc$116.00$122.00▼ 5%+12%+9%
2026-09-30Mizuho Securities$113.00$124.00▼ 9%+13%+7%
2026-09-29Scotiabank$104.00——+5%-2%
2026-09-25RBC Capital$107.00$116.00▼ 8%+9%+1%
2026-07-23BTIG$126.00$131.00▼ 4%+12%+19%
2026-07-22Morgan Stanley$118.00$115.00▲ 3%+6%+11%

Consensus estimates

revenue and EPS by fiscal year · reported years marked
FYRevenueYoYEPSYoYRevenue rangeEPS rangeAnalysts
2023reported$7.5B-6%$4.38+6%est. $8.0B-6%est. $4.387
2024reported$7.6B+2%$4.42+1%est. $7.6B+1%est. $4.637
2025reported$8.8B+15%$5.35+21%est. $8.6B+2%est. $5.028
2026$9.0B+3%$5.39+7%$8.8B–$9.4B$5.37–$5.419
2027$9.6B+6%$5.81+8%$9.4B–$10.1B$5.72–$5.889
2028$10.3B+7%$6.32+9%$9.4B–$11.1B$6.26–$6.3911
2029$10.9B+6%$6.85+8%$10.2B–$11.6B$6.31–$7.405
2030$11.6B+6%$7.49+9%$10.9B–$12.3B$6.91–$8.095
A reported year shows the company's figures, with the consensus beside it (revenue against it in %). Reported EPS is GAAP diluted; the analysts' EPS usually leaves items such as stock compensation out, so the two are not like for like. Faded: a year the valuation models do not read — they read the first 3, and a later one only while 10 or more analysts cover every year up to it — or one under 5 analysts.

Targets, grades and estimates are quoted from third parties (via Financial Modeling Prep) and are theirs, not ours; each target links to the report it was published in. A firm counts once, at its latest target or grade.